Fetal Alcohol Syndrome/ARND Research Consortion

Status Completed

Clinical Trial Summary

Children will receive comprehensive evaluations through the UOHSC ABC program The assessment for the child will include: medical issues (including medication), dysmorphic examination, intellectual assessment, academic achievement, language, and motor skills. This program will provide appropriate non-study services and referrals. Eligible families will be randomly assigned to treatment group or control group. Treatment group will receive Parent Child Interaction Therapy (PCIT). The Control group will receive standard referrals and services through the ABC program and the parent education/advocacy component of the project.

Clinical Trial Description

PCIT has been adapted by the applicant for group administration. The intervention will consist of 90-minute sessions of PCIT once a week for 14 weeks. During PCIT sessions parents and children will participate in activities that promote interactions. A behavior specialist who will be observing through a two-way mirror assists parents in development of appropriate behaviors and interaction techniques. Parents will be prompted by use of in-ear devices (i.e., bug in the ear). This intervention has been shown to be effective in other populations. For each family, individualized goals for parent-child interactions will be set and reviewed each session. Homework assignments also will be given.

Parent Component: Three 90-minute sessions conducted in a group format. Topics will include: FAS/ARND education, impact of FAS/ARND on families, specific development of a child with FAS/ARND, and FAS/ARND social skills and deficits.

Evaluation Plan: Treatment and control groups will be compared using pre- and post-tests measures. Post-tests will be at the conclusion of the intervention and at a 6, 12, and 18-month follow-ups. Process (e.g., parent satisfaction, compliance, etc) and outcome (e.g., behavior, family functioning, etc) measures will be evaluated. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00164554
Study type	Interventional
Source	Centers for Disease Control and Prevention
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	October 2001
Completion date	June 2005

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06163651` - Evaluating a One-Year Version of the Parent-Child Assistance Program	N/A
Active, not recruiting	`NCT00996528` - Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)	Phase 3
Completed	`NCT00164229` - Fetal Alcohol Syndrome: Socio-Cognitive Habilitation	Phase 1/Phase 2
Recruiting	`NCT05534568` - The Oklahoma Parent-Child Assistance Program	N/A
Recruiting	`NCT05385328` - Multisensorial Analysis of Human Activity for Diagnosis and Early Detection of Functional Limitations
Completed	`NCT01911299` - Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders	Phase 2
Terminated	`NCT00747630` - Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)	Phase 0
Recruiting	`NCT04332172` - Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy	N/A
Completed	`NCT00696085` - Fetal Alcohol Damage Prevention Study	N/A
Recruiting	`NCT00418262` - Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD	Phase 3
Completed	`NCT01149538` - Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure	Phase 1/Phase 2
Recruiting	`NCT03371641` - In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions	N/A
Completed	`NCT00164346` - Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)	Phase 1/Phase 2
Completed	`NCT01994603` - Expansion to Interdisciplinary HIV Prevention in Women	N/A
Completed	`NCT00417794` - Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD	Phase 1
Completed	`NCT02600624` - Prenatal Alcohol Biomarker Study in Uruguay
Completed	`NCT00244062` - Healthy Moms Alcohol Intervention	N/A
Recruiting	`NCT04395196` - RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.